Bio-Rad Laboratories (BIO) EPS (Basic) (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported EPS (Basic) for 18 consecutive years, with $13.89 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EPS (Basic) rose 18.96% year-over-year to $13.89 in Q2 2026; TTM through Jun 2026 was $8.32, a 29.08% decrease from a year earlier, with the FY2025 full-year figure at $27.87, up 142.64% from the prior year.
• EPS (Basic) was $13.89 for Q2 2026 at Bio-Rad Laboratories, up from -$19.55 in the prior quarter.
• Over five years, EPS (Basic) peaked at $27.79 in Q4 2022 and troughed at -$112.5 in Q1 2022.
• A 5-year average of -$10.31 and a median of $2.31 in 2023 frame the typical range for EPS (Basic).
• Across the five-year window, EPS (Basic) jumped 540.1% in 2024 and plunged 953.63% in 2026, its largest moves.
• Over 5 years, EPS (Basic) stood at $27.79 in 2022, then plunged by 56.92% to $11.97 in 2023, then slumped by 311.89% to -$25.37 in 2024, then soared by 204.1% to $26.41 in 2025, then plunged by 47.42% to $13.89 in 2026.
• The last three EPS (Basic) figures came in at $13.89 (Q2 2026), -$19.55 (Q1 2026), and $26.41 (Q4 2025), per Business Quant data.